March 27, 2014 | Clinical news and product releases from the past month:

Exco InTouch, a provider of patient engagement and data capture solutions, will unveil the Exco Valued Partner Network at the Partnerships in Clinical Trials Congress in Las Vegas this weekend. The Valued Partner Network will connect Exco InTouch’s pool of partners for collaborative activities through the Exco Partner Cloud, a secure web portal that supports partner business development teams. The cloud enables partners to access tailored demonstrations, videos, case studies and co-branded materials, as well as providing information on their experience working together. Members of the Valued Partner Network will have access to executive team leaders assigned to each partnership, preferred pricing, and other forms of business support. Press release 

Spark Therapeutics and Genable Technologies announced a collaboration to develop and produce a gene therapy product, centered on Genable’s lead therapeutic to treat rhodopsin-linked autosomal dominant retinitis pigmentosa. Genable will license adeno-associated virus vector manufacturing patents from Spark, which will become the exclusive manufacturer of the product and aid in its ongoing development. Press release 

The Children’s Hospital of Philadelphia Center for Biomedical Informatics introduced Proband, an app allowing genetic counselors and other healthcare providers to create pedigrees on an iPad. Users can store the pedigrees in a standardized format, make corrections, and export the diagrams so they can be used in other applications such as electronic medical records. Proband uses a simple, gesture-based interface to make drawing pedigrees in the app as efficient as drawing on paper. Press release 

Insight Genetics, Inc. is collaborating with Vanderbilt-Ingram Cancer Center (VICC) to refine the classification and treatment of patients diagnosed with triple-negative breast cancer (TNBC). Insight Genetics will identify genetic markers to help select the targeted therapeutics most effective for each individual TNBC patient. The project will build on work by Jennifer Pietenpol’s lab at VICC, examining gene expression data from more than 500 TNBC cases and identifying up to six distinct sub-types of triple-negative breast cancers. Press release 

EMC added Documentum R&D to its Life Sciences Solution Suite 3.0. As part of the Solution Suite, Documentum R&D is designed to streamline the regulatory submissions process. It includes a content repository to manage documents, template-based processing, and collaborative authoring capabilities, while maintaining compliance with regulatory requirements. Product page 

Veeva Systems introduced Veeva CRM Engage, a cloud-based application for interaction between life sciences organizations and healthcare professionals over the web and through mobile devices. Engage adds an online channel to Veeva’s Commercial Suite, which also supports face-to-face, phone, and email customer interactions. Engage also captures all web activities in Veeva CRM for further analysis, so companies can adapt digital content to accommodate physician preferences. Press release 

C3i was selected by CFS Clinical to provide global multilingual technology support services for their Site Activation and Investigator Payment Services. The service desk is supporting active clinical trial sites in nearly 50 countries and 12 languages. Later in 2014, additional languages will be added to manage CFS’ continued scaling, supported out of C3i’s Dalian Operations Center. Press release